KELLY BAKER: Open Payments
NPI 1396761235 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$449 in 20 payments from 10 companies in 2025. Trend: 2023 $376 · 2024 $405 · 2025 $449
Food & beverage: $449
| Company | Payments | Amount |
|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $122 |
| Corium, LLC | 6 | $95 |
| GlaxoSmithKline, LLC. | 3 | $64 |
| Exact Sciences Corporation | 2 | $33 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Novo Nordisk Inc | 2 | $31 |
| Verity Pharmaceuticals Inc. | 1 | $25 |
| Acella Pharmaceuticals, LLC | 1 | $18 |
| Cranial Technologies, Inc | 1 | $14 |
| TOLMAR, INC. | 1 | $14 |
Products named: JOURNAVX, Azstarys, TRELEGY ELLIPTA, Cologuard Collection Kit, Tlando, NP Thyroid 60, AIRSUPRA, BREZTRI.
Industry payments across TX — which companies pay providers there.
